MedTrace Logo

Smartphone App and CO Self-monitoring for Smoking Cessation

NCT02840513 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-07-10

No results posted yet for this study

Summary

This randomized controlled trial is going to evaluate whether an intervention consisting of a smartphone application to assist smokers living with HIV to quit in combination with CO self-monitoring compared to stop smoking counselling by physicians during usual care results in higher self-reported and biochemically verified smoking cessation rates at 6 months.

.

Conditions

Interventions

OTHER

Smartphone app/CO self-monitoring

Smartphone app and carbon monoxide self-monitoring (personal device)

Sponsors & Collaborators

  • Alain Nordmann

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-06-24
Completion
2019-06-24

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02840513 on ClinicalTrials.gov